Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE3
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
- Status
- TERMINATED
- Phase
- PHASE2
Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults
- Status
- UNKNOWN
- Phase
- N/A
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- N/A
Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Exploratory Study of Natural Killer Cells in Human Skin
- Status
- COMPLETED
- Phase
- NA
Study of MEDI 507 in the Treatment of Pediatric Patients
- Status
- COMPLETED
- Phase
- PHASE1
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
- Status
- TERMINATED
- Phase
- N/A
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning
- Status
- TERMINATED
- Phase
- PHASE2
Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
- Status
- UNKNOWN
- Phase
- PHASE2
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT
- Status
- TERMINATED
- Phase
- PHASE3